Searched over 200M research papers
10 papers analyzed
These studies suggest emphysema is a chronic obstructive pulmonary disease characterized by the destruction of lung tissue, leading to enlarged airspaces, reduced airflow, and symptoms like shortness of breath, primarily caused by smoking and long-term exposure to airborne irritants.
19 papers analyzed
Emphysema is a chronic obstructive pulmonary disease (COPD) characterized by the abnormal, permanent enlargement of air spaces distal to the terminal bronchioles, accompanied by the destruction of alveolar walls without obvious fibrosis . This condition leads to a reduction in the surface area available for gas exchange, causing significant respiratory impairment .
The primary causes of emphysema include long-term exposure to airborne irritants such as tobacco smoke, air pollution, and chemical fumes . Additionally, a genetic deficiency in alpha-1 antitrypsin (AATD) can lead to emphysema, particularly in non-smokers . Smoking remains the most significant risk factor, contributing to the majority of emphysema cases .
Emphysema involves the destruction of lung parenchyma, leading to the loss of elasticity in lung tissue. This destruction is primarily due to an imbalance between proteases and antiproteases, increased oxidative stress, and impaired repair mechanisms. The disease manifests through the collapse of small airways during exhalation, trapping air in the lungs and impeding airflow .
Emphysema can be classified into several types based on the affected areas of the lung acinus:
Patients with emphysema typically experience progressive shortness of breath, initially on exertion and later at rest. Other symptoms include hyperventilation and an expanded chest due to trapped air . The disease can significantly reduce exercise capacity and overall quality of life.
Diagnosis of emphysema often involves pulmonary function tests (PFTs) and imaging techniques such as chest computed tomography (CT). CT scans can detect low attenuation areas in lung tissue, which are indicative of emphysema . These imaging techniques help distinguish emphysema from other lung conditions like interstitial lung disease and cystic lung disease.
Management of emphysema includes smoking cessation, pharmacological treatments, and in severe cases, lung volume reduction surgery. Current pharmacological treatments are less effective in emphysematous patients compared to those with other forms of COPD. Emerging therapies aim to decelerate proteolysis and restore lung tissue damage, with promising candidates including Vitamin A/K, hyaluronan, copper, and roflumilast.
Emphysema is a debilitating lung disease primarily caused by smoking and genetic factors. It involves the destruction of alveolar walls, leading to impaired respiratory function. Early diagnosis and management are crucial to improving patient outcomes, with ongoing research focusing on novel therapeutic approaches to mitigate lung tissue damage and enhance quality of life for those affected.
Most relevant research papers on this topic